The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
about
Cyclic AMP Represents a Crucial Component of Treg Cell-Mediated Immune RegulationAntipsychotic-associated psoriatic rash - a case report.Modulation of Phenotype and Function of Human CD4+CD25+ T Regulatory Lymphocytes Mediated by cAMP-Elevating AgentsPK/PD studies on non-selective PDE inhibitors in rats using cAMP as a marker of pharmacological response.Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF).Metabolic signatures of T-cells and macrophages in rheumatoid arthritis.Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice.Intracellular signaling by second messengersCircadian clock cryptochrome proteins regulate autoimmunity.Rolipram, a Selective Phosphodiesterase 4 Inhibitor, Ameliorates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain through Inhibition of Inflammatory Cytokines in the Dorsal Root Ganglion.Frontiers in Medicinal Chemistry 2017 in Bern, Switzerland.Histamine receptor 2 modifies iNKT cell activity within the inflamed lung.Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions.Adenylate Cyclases of Trypanosoma brucei, Environmental Sensors and Controllers of Host Innate Immune Response.Immune-Modulating Perspectives for Low Frequency Electromagnetic Fields in Innate Immunity.A Novel Catecholopyrimidine Based Small Molecule PDE4B Inhibitor Suppresses Inflammatory Cytokines in Atopic Mice.Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.The Eye, Oxidative Damage and Polyunsaturated Fatty Acids.Effects of rheumatoid arthritis associated transcriptional changes on osteoclast differentiation network in the synovium
P2860
Q28072162-E5BAFBD1-D7C4-4870-A207-DDD28FA1E120Q33870010-4B2B201B-C542-4D93-A7B4-2BDC96D6485BQ37266957-49AF8548-D939-48BF-A6D1-E4C0BC8F3903Q38653998-C1A53B80-4CC2-4EE2-8B9A-DC1475D23208Q39268911-67E10E24-8983-4746-A662-05E02C6CE801Q39326409-D6B3161E-9CCF-4260-85C5-0A5DC117E3A0Q40158098-037F0824-B381-436E-8CA6-39A4C69A61C9Q45318291-3F96B8E1-4209-4D11-9B7B-4F562F3A1FAEQ46273899-0FD715C9-F8D3-451A-850E-6E89459E2C5BQ47136755-D3B9EAE8-9211-4BD6-BC54-7CD6E7A7E0F2Q47262276-B6883C59-D447-4B20-AF78-E610AC74971FQ47861821-86B8F9F2-5316-480D-B10C-64F6532E80E0Q49328492-FE9B93DD-9A74-44FF-94F7-B6CC508B1F44Q52310146-DF6E246A-FEF0-4CA3-9AA7-1E2142B0C1A9Q52720449-AE82EC3E-6A4E-4FEA-9F57-46DFBAA5B178Q55048045-3B85AF52-B63D-4944-8908-A050EE9A0452Q55266660-A03A2FA6-F067-4D49-A872-48A6AEC6CB0EQ55515186-37FAA8CD-8401-435C-AAE3-553CC05B6120Q57476671-F1FF8376-F6D8-49EA-8385-3A716F074C67
P2860
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
@ast
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
@en
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
@nl
type
label
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
@ast
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
@en
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
@nl
prefLabel
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
@ast
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
@en
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
@nl
P2860
P3181
P356
P1476
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
@en
P2093
Kerstin Steinbrink
P2860
P3181
P356
10.3389/FIMMU.2016.00123
P407
P577
2016-03-31T00:00:00Z